Avantor Stock (NYSE:AVTR)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$25.13

52W Range

$16.63 - $28.00

50D Avg

$25.78

200D Avg

$24.11

Market Cap

$17.21B

Avg Vol (3M)

$7.89M

Beta

1.33

Div Yield

-

AVTR Company Profile


Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.

Show More

Industry

Chemicals - Specialty

Sector

Basic Materials

Exchange

NYSE

ADR

-

Country

US

Employees

14,500

IPO Date

May 17, 2019

Website

AVTR Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 23Dec 22Dec 21
Third Party Materials And Consumables$2.54B$2.70B$2.91B
Proprietary Materials And Consumables$2.54B$2.90B$2.55B
Services And Specialty Procurement$963.50M$921.00M$922.60M
Equipment And Instrumentation$928.00M$988.90M$1.01B

Fiscal year ends in Dec 23 | Currency in USD

AVTR Financial Summary


Dec 23Dec 22Dec 21
Revenue$6.97B$7.51B$7.39B
Operating Income$696.40M$1.13B$972.20M
Net Income$321.10M$662.30M$572.60M
EBITDA$1.26B$1.53B$1.36B
Basic EPS$0.48$1.02$0.86
Diluted EPS$0.47$1.01$0.85

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q2 24Jul 26, 24 | 10:59 AM
Q1 24Apr 26, 24 | 12:00 AM
Q4 23Feb 14, 24 | 2:46 PM

Peer Comparison


TickerCompany
ESIElement Solutions Inc
SXTSensient Technologies Corporation
ECVTEcovyst Inc.
FULH.B. Fuller Company
ODCOil-Dri Corporation of America
CBTCabot Corporation
IOSPInnospec Inc.
KWRQuaker Chemical Corporation
ASHAshland Inc.
AXTAAxalta Coating Systems Ltd.
BCPCBalchem Corporation
MTXMinerals Technologies Inc.
AVNTAvient Corporation